IDH1 and cancer: IDH enzymes (Appendix Fig S5A) are responsible for the conversion of isocitrate to alpha‐ketoglutarate, and their mutation in cancer is associated with an oncogenic build‐up of 2‐hydroxyglutarate due to a change in catalytic activity (Losman & Kaelin, 2013).